Sonoma Pharmaceuticals, Inc.
SNOA
Price:
$3.2
Market Cap:
$5.26M
Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions in the United States, Latin America, Europe, and internationally. The company offers Epicyn, an antimicrobial facial cleanser; Levicyn, an HOCl based prescription product to manage and relieve burning, itching, and pain experienced with various types of dermatoses; Celacyn gel, a HOCl-based topical prescription product indicated to promote efficient healing through the management of new and old scars; and SebuDerm to manage and relieve the burning, itching, erythema, scaling, and pain associated with seborrhea ...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2007-01-25
Stock Exchange
NASDAQ
Ticker
SNOA
PE Ratio
[-1.15]
ROE
[-70.52%]
Current Ratio
[3.09]
Dividend Yield
[0%]
Enterprise Value
[187.86K]
Dividend History
The ROE as of July 2025 (TTM) for Sonoma Pharmaceuticals, Inc. (SNOA) is -70.52%
According to Sonoma Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is -70.52%. This represents a change of 297.19% compared to the average of -17.76% of the last 4 quarters.
Sonoma Pharmaceuticals, Inc. (SNOA) Historical ROE (quarterly & annually)
How has SNOA ROE performed in the past?
The mean historical ROE of Sonoma Pharmaceuticals, Inc. over the last ten years is -66.30%. The current -70.52% ROE has changed 6.37% with respect to the historical average. Over the past ten years (40 quarters), SNOA's ROE was at its highest in in the December 2016 quarter at 70.98%. The ROE was at its lowest in in the March 2021 quarter at -68.25%.
Average
-66.30%
Median
-78.58%
Minimum
-112.48%
Maximum
43.27%
Sonoma Pharmaceuticals, Inc. (SNOA) ROE by Quarter and Year
Discovering the peaks and valleys of Sonoma Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 154.27%
Maximum Annual ROE = 43.27%
Minimum Annual Increase = -316.04%
Minimum Annual ROE = -112.48%
| Year | ROE | Change |
|---|---|---|
| 2025 | -78.37% | -0.52% |
| 2024 | -78.78% | 22.01% |
| 2023 | -64.57% | 10.42% |
| 2022 | -58.48% | -32.04% |
| 2021 | -86.05% | 154.27% |
| 2020 | -33.84% | -69.91% |
| 2019 | -112.48% | 20.31% |
| 2018 | -93.49% | -316.04% |
| 2017 | 43.27% | -143.18% |
| 2016 | -100.22% | 47.27% |
Sonoma Pharmaceuticals, Inc. (SNOA) Average ROE
How has SNOA ROE performed in the past?
The current ROE of Sonoma Pharmaceuticals, Inc. (SNOA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-73.91%
5-year avg
-73.25%
10-year avg
-66.30%
Sonoma Pharmaceuticals, Inc. (SNOA) ROE vs. Peers
How is SNOA’s ROE compared to its peers?
Sonoma Pharmaceuticals, Inc.’s ROE is less than China SXT Pharmaceuticals, Inc. (47.36%), greater than Biofrontera Inc. (-216.00%), greater than Sonnet BioTherapeutics Holdings, Inc. (-777.96%), greater than Phio Pharmaceuticals Corp. (-105.65%), greater than Edesa Biotech, Inc. (-103.09%), greater than Xenetic Biosciences, Inc. (-57.29%), greater than NanoVibronix, Inc. (-54.73%),
| Company | ROE | Market cap |
|---|---|---|
| 47.36% | $205.37M | |
| -216.00% | $7.93M | |
| -777.96% | $14.69M | |
| -105.65% | $11.95M | |
| -103.09% | $14.78M | |
| -57.29% | $6.34M | |
| -54.73% | $2.46M |
Build a custom stock screener for Sonoma Pharmaceuticals, Inc. (SNOA) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sonoma Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Sonoma Pharmaceuticals, Inc. (SNOA) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Sonoma Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Sonoma Pharmaceuticals, Inc.'s ROE?
How is the ROE calculated for Sonoma Pharmaceuticals, Inc. (SNOA)?
What is the highest ROE for Sonoma Pharmaceuticals, Inc. (SNOA)?
What is the 3-year average ROE for Sonoma Pharmaceuticals, Inc. (SNOA)?
What is the 5-year average ROE for Sonoma Pharmaceuticals, Inc. (SNOA)?
How does the current ROE for Sonoma Pharmaceuticals, Inc. (SNOA) compare to its historical average?